Hematology products & services segment accounted for the largest market share in 2019.
Based on products & services, the hematology analyzers and reagents market is classified into hematology, hemostasis, and immunohematology products & services. The hematology products & services segment accounted for the largest market share in 2019. This can be attributed to the increasing adoption of POC testing hematology analyzers in emerging economies, the launch of technologically advanced hematology products, the increasing preference for automation, and the availability of a wide range of services from major hematology providers.

The low-end hematology analyzers segment accounted for the largest share of the global hematology instruments market, by price range, in 2019.
By price range, the hematology instruments market is classified into high-end, mid-range, and low-end hematology analyzers. The low-end hematology analyzers segment accounted for the largest share of the global hematology instruments market in 2019.

The commercial service providers segment accounted for the largest share of the market, by end user, in 2019.
On the basis of end user, the hematology products & services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market owing to the increasing incidence of leukemia and anemia, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection)